Literature DB >> 1516261

T cell responses to synthetic TSH receptor peptides in Graves' disease.

N Tandon1, M A Freeman, A P Weetman.   

Abstract

Twenty-eight peptides, representing the entire extracellular domain of the TSH receptor, were synthesised to investigate which parts of this autoantigen may be targets for the T cell response in Graves' disease (GD). T cells from 11 of 21 controls and 26 of 36 newly diagnosed GD patients proliferated in response to one or more peptides with a stimulation index (SI) of greater than 2.0 (chi 2 = 2.31, P greater than 0.1). The response of patients and controls to any of the individual peptides was also not statistically different. However, individual patients gave high SIs with certain peptides to which controls either gave an absent or very weak response. HLA-DR3 was not associated with any particular response to TSHR peptides. Three out of seven GD patients whose T cells were evaluated before and after treatment showed a response of this kind only early in the course of their disease. Intrathyroidal T cells from four GD patients did not give a consistent proliferative response to pools of five peptides, and depleting peripheral blood T cells of their CD8+ population did not affect the proliferative response. These results indicate that the T cell response to the TSH receptor in GD does not seem to be directed against any one particular epitope on the peptides we have tested which cover the extracellular domain.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1516261      PMCID: PMC1554462          DOI: 10.1111/j.1365-2249.1992.tb06982.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  30 in total

1.  General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids.

Authors:  R A Houghten
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

2.  Cloning, sequencing and expression of the human thyrotropin (TSH) receptor: evidence for binding of autoantibodies.

Authors:  F Libert; A Lefort; C Gerard; M Parmentier; J Perret; M Ludgate; J E Dumont; G Vassart
Journal:  Biochem Biophys Res Commun       Date:  1989-12-29       Impact factor: 3.575

3.  Thyroperoxidase, but not the thyrotropin receptor, contains sequential epitopes recognized by autoantibodies in recombinant peptides expressed in the pUEX vector.

Authors:  F Libert; M Ludgate; C Dinsart; G Vassart
Journal:  J Clin Endocrinol Metab       Date:  1991-10       Impact factor: 5.958

4.  Sequences of the mouse F protein alleles and identification of a T cell epitope.

Authors:  J P Schofield; R K Vijayakumar; D B Oliveira
Journal:  Eur J Immunol       Date:  1991-05       Impact factor: 5.532

Review 5.  Autoantibodies to the thyrotropin receptor.

Authors:  B Rees Smith; S M McLachlan; J Furmaniak
Journal:  Endocr Rev       Date:  1988-02       Impact factor: 19.871

6.  Response of peripheral-blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes.

Authors:  M A Atkinson; D L Kaufman; L Campbell; K A Gibbs; S C Shah; D F Bu; M G Erlander; A J Tobin; N K Maclaren
Journal:  Lancet       Date:  1992-02-22       Impact factor: 79.321

7.  The in vitro regulation of human thyrocyte HLA-DR antigen expression.

Authors:  A P Weetman; D J Volkman; K D Burman; T L Gerrard; A S Fauci
Journal:  J Clin Endocrinol Metab       Date:  1985-11       Impact factor: 5.958

8.  Possible binding site of thyrotropin binding inhibitor immunoglobulin (TBII) on the thyrotropin (TSH) receptor, which is different from TSH binding site.

Authors:  T Piraphatdist; H Sugawa; D Inoue; T Enomoto; T Mori; H Imura
Journal:  Biochem Biophys Res Commun       Date:  1990-10-30       Impact factor: 3.575

9.  Autologous CD8-positive cells suppress T cell proliferation in response to thyroid antigens in Hashimoto's thyroiditis.

Authors:  A P Weetman
Journal:  Clin Immunol Immunopathol       Date:  1989-05

10.  A sequence pattern common to T cell epitopes.

Authors:  J B Rothbard; W R Taylor
Journal:  EMBO J       Date:  1988-01       Impact factor: 11.598

View more
  8 in total

1.  No restriction of intrathyroidal T cell receptor V alpha families in the thyroid of Graves' disease.

Authors:  R S McIntosh; P F Watson; A P Pickerill; R Davies; A P Weetman
Journal:  Clin Exp Immunol       Date:  1993-01       Impact factor: 4.330

2.  Identification of thyroid stimulating hormone receptor-specific T cells in Graves' disease thyroid using autoantigen-transfected Epstein-Barr virus-transformed B cell lines.

Authors:  R J Mullins; S B Cohen; L M Webb; Y Chernajovsky; C M Dayan; M Londei; M Feldmann
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

3.  Increased bcl-2 expression in lymphocytes and its association with hepatocellular damage in patients with autoimmune hepatitis.

Authors:  M Yachida; K Kurokohchi; K Arima; M Nishioka
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

4.  T lymphocyte responses to anti-neutrophil cytoplasmic autoantibody (ANCA) antigens are present in patients with ANCA-associated systemic vasculitis and persist during disease remission.

Authors:  W J King; C J Brooks; R Holder; P Hughes; D Adu; C O Savage
Journal:  Clin Exp Immunol       Date:  1998-06       Impact factor: 4.330

5.  Evaluation of T cell stimulation by thyrotropin-receptor epitopes in Graves' disease.

Authors:  L J De Groot; Y Ha Shin; D Pan; G Gopalakrishnan; J V Hennessey
Journal:  J Endocrinol Invest       Date:  2009-01       Impact factor: 4.256

6.  Analysis of T cell responses to the autoantigen in Goodpasture's disease.

Authors:  C J Derry; C N Ross; G Lombardi; P D Mason; A J Rees; R I Lechler; C D Pusey
Journal:  Clin Exp Immunol       Date:  1995-05       Impact factor: 4.330

Review 7.  Thyrotropin Receptor Epitope and Human Leukocyte Antigen in Graves' Disease.

Authors:  Hidefumi Inaba; Leslie J De Groot; Takashi Akamizu
Journal:  Front Endocrinol (Lausanne)       Date:  2016-08-23       Impact factor: 5.555

8.  Immunomodulation of RA Patients' PBMC with a Multiepitope Peptide Derived from Citrullinated Autoantigens.

Authors:  Smadar Gertel; Gidi Karmon; Sivan Vainer; Ora Shovman; Martin Cornillet; Guy Serre; Yehuda Shoenfeld; Howard Amital
Journal:  Mediators Inflamm       Date:  2017-06-21       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.